Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report)’s stock price traded up 9% on Friday . The stock traded as high as $11.36 and last traded at $11.5340. 517,677 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 861,052 shares. The stock had previously closed at $10.58.
Wall Street Analyst Weigh In
LMRI has been the subject of a number of recent analyst reports. Weiss Ratings upgraded shares of Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a report on Monday, June 1st. Barclays lowered their price objective on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Lumexa Imaging has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.
Get Our Latest Analysis on Lumexa Imaging
Lumexa Imaging Stock Performance
Insider Activity
In related news, Director Brett Brodnax purchased 35,000 shares of Lumexa Imaging stock in a transaction dated Tuesday, May 19th. The shares were acquired at an average cost of $7.25 per share, with a total value of $253,750.00. Following the purchase, the director owned 62,027 shares of the company’s stock, valued at approximately $449,695.75. The trade was a 129.50% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.70% of the company’s stock.
Institutional Trading of Lumexa Imaging
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its stake in Lumexa Imaging by 1,855,116.7% during the first quarter. Bank of America Corp DE now owns 111,313 shares of the company’s stock worth $957,000 after purchasing an additional 111,307 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of Lumexa Imaging by 5.4% in the first quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock valued at $18,063,000 after buying an additional 107,903 shares in the last quarter. Readystate Asset Management LP grew its stake in shares of Lumexa Imaging by 60.5% in the first quarter. Readystate Asset Management LP now owns 224,755 shares of the company’s stock valued at $1,933,000 after buying an additional 84,755 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Lumexa Imaging in the 1st quarter valued at $778,000. Finally, Sei Investments Co. lifted its stake in Lumexa Imaging by 339.6% during the 1st quarter. Sei Investments Co. now owns 88,190 shares of the company’s stock worth $758,000 after acquiring an additional 68,127 shares in the last quarter.
About Lumexa Imaging
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Featured Articles
- Five stocks we like better than Lumexa Imaging
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
